---
title: CONTINUUS Pharmaceuticals vs Micromacinazione
slug_a: continuuspharma
slug_b: micromacinazione
site: cdmo
review_signal_gate: closed
canonical_path: /compare/continuuspharma/micromacinazione
---

# CONTINUUS Pharmaceuticals vs Micromacinazione

Side-by-side profile data from each company listing on this directory.

## CONTINUUS Pharmaceuticals

- Profile: [/companies/continuuspharma](/companies/continuuspharma)

CONTINUUS Pharmaceuticals — CONTINUUS Pharmaceuticals specializes in Integrated Continuous Manufacturing (ICM)—a transformative approach that replaces traditional batch processes with end-to-end continuous flows for active pharmaceutical ingredients (APIs) and final dosage forms.

Services: 6. Modalities: 1. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development

### Modalities

- Small Molecule

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Flow Chemistry

## Micromacinazione

- Profile: [/companies/micromacinazione](/companies/micromacinazione)

Micromacinazione — Swiss-based CDMO specializing in particle engineering and micronization with over 50 years of experience. Offers micronization, milling, spray drying, solid-state characterization, and complementary processing services (classification, blending, cryogenic, co-micronization, conditioning) for APIs, HPAPIs, controlled substances, and excipients from early development to commercial GMP scale.

Services: 6. Modalities: 1. Indications: 0. Locations: 2. Certifications: 1. The strongest documented coverage currently appears in services (6).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Solid-State Chemistry & Polymorph Screening
- Process Development
- CMC Analytical Development

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Cryogenic (−80 °C)